The information
in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement and the accompanying
prospectus, prospectus supplement and underlying supplement do not constitute an offer to sell the securities and we are not soliciting
an offer to buy the securities in any state where the offer or sale is not permitted.
Subject
to Completion. Dated June 23, 2025 |
 |
June
2025
Registration
Statement No. 333-287303
Pricing
Supplement dated June , 2025
Filed
pursuant to Rule 424(b)(2) |
Structured
Investments
Opportunities in U.S. and International Equities
Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI
EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
Unlike conventional debt securities, the securities do not guarantee
the payment of interest or the return of the full principal amount at maturity. Instead, the securities offer the opportunity for investors
to receive a contingent quarterly payment equal to at least 2.00% of the stated principal amount (the actual contingent quarterly payment
will be determined on the pricing date) with respect to each quarterly determination date on which the closing level of each underlier
is greater than or equal to 70% of its initial underlier value, which we refer to as a coupon barrier level. However, if on any determination
date the closing level of any underlier is less than its coupon barrier level, investors will not receive any contingent quarterly
payment for the related quarterly period. In addition, on any contingent payment date (other than the final contingent payment date),
we will have the right to redeem the securities at our discretion for an amount per security equal to the stated principal amount
plus any contingent quarterly payment otherwise due. Any early redemption of the securities will be at our discretion and will
not automatically occur based on the performance of the underliers. If the securities are not redeemed prior to maturity and the final
underlier value of each underlier is greater than or equal to 60% of its initial underlier value, which we refer to as a downside
threshold level, the payment at maturity due on the securities will be equal to the stated principal amount plus any contingent
quarterly payment otherwise due. However, if the securities are not redeemed prior to maturity and the final underlier value of any
underlier is less than its downside threshold level, at maturity investors will lose 1% of the stated principal amount for every 1% that
the final underlier value of the worst performing underlier is less than its initial underlier value. Under these circumstances, the
amount investors receive will be less than 60% of the stated principal amount and could be zero. Because all payments on the securities
are based on the worst performing of the underliers, (i) a decline in the closing level of any underlier below its coupon barrier
level on most or all of the determination dates will result in few or no contingent quarterly payments and (ii) a decline in the closing
level of any underlier below its downside threshold level on the final determination date will result in a significant loss of
your investment, in each case, even if the other underliers appreciate or have not declined as much. The securities are for investors
who are willing and able to risk their principal and forgo guaranteed interest payments, in exchange for the opportunity to potentially
receive contingent quarterly payments at an above-market rate, subject to early redemption at our discretion. Investors will not participate
in any appreciation of any underlier even though investors will be exposed to the depreciation in the value of the worst performing underlier
if the securities have not been redeemed prior to maturity and the final underlier value of the worst performing underlier is less than
its downside threshold level. Investors may lose their entire initial investment in the securities.
The securities are unsecured and unsubordinated debt obligations of Barclays Bank PLC. Any payment on the securities, including any repayment
of principal, is subject to the creditworthiness of Barclays Bank PLC and is not guaranteed by any third party. If Barclays Bank PLC
were to default on its payment obligations or become subject to the exercise of any U.K. Bail-in Power (as described on page 5 of this
document) by the relevant U.K. resolution authority, you might not receive any amounts owed to you under the securities. See “Risk
Factors” and “Consent to U.K. Bail-in Power” in this document and “Risk Factors” in the accompanying prospectus
supplement.
SUMMARY TERMS* |
|
Issuer: |
Barclays Bank PLC |
Reference assets: |
MSCI EAFE® Index (the “MXEA Index”), Russell 2000® Index (the “RTY Index”) and S&P 500® Index (the “SPX Index”) (each an “underlier” and together the “underliers”) |
|
Underlier |
Bloomberg ticker |
Initial underlier value(1) |
Coupon barrier level(2) |
Downside threshold level(3) |
|
MXEA Index |
MXEA<Index> |
|
|
|
|
RTY Index |
RTY<Index> |
|
|
|
|
SPX Index |
SPX<Index> |
|
|
|
|
(1) With respect
to each underlier, the closing level of that underlier on the pricing date
(2) With respect
to each underlier, 70% of its initial underlier value (rounded to two decimal places for
the MXEA Index and the SPX Index and rounded to three decimal places for the RTY Index)
(3) With respect
to each underlier, 60% of its initial underlier value (rounded to two decimal places for
the MXEA Index and the SPX Index and rounded to three decimal places for the RTY Index) |
Aggregate principal amount: |
$ |
Stated principal amount: |
$1,000 per security |
Pricing date†: |
June 27, 2025 |
Original issue date: |
July 2, 2025 |
Maturity date†: |
July 2, 2030 |
Contingent quarterly payment: |
· If,
on any determination date, the closing level of each underlier is greater than or equal to its coupon barrier level, we will pay
a contingent quarterly payment of at least $20.00 (at least 2.00% of the stated principal amount) per security on the related contingent
payment date. The actual contingent quarterly payment will be determined on the pricing date.
· If,
on any determination date, the closing level of any underlier is less than its coupon barrier level, no contingent quarterly payment
will be made with respect to that determination date. |
Payment at maturity: |
If the securities are not redeemed prior to maturity, you will
receive on the maturity date a cash payment per security determined as follows:
· If
the final underlier value of each underlier is greater than or equal to its downside threshold level:
(i) stated principal amount plus
(ii) any contingent quarterly payment otherwise due
· If
the final underlier value of any underlier is less than its downside threshold level:
stated principal amount × underlier
performance factor of the worst performing underlier
Under these circumstances, the payment at maturity will be
less than the stated principal amount of $1,000 and will represent a loss of more than 40%, and possibly all, of an investor’s
initial investment. Investors may lose their entire initial investment in the securities. Any payment on the securities, including any
repayment of principal, is not guaranteed by any third party and is subject to (a) the creditworthiness of Barclays Bank PLC and (b)
the risk of exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority. |
U.K. Bail-in Power acknowledgment: |
Notwithstanding and to the exclusion of any other term of the securities or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial owner of the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial owner of the securities acknowledges, accepts, agrees to be bound by and consents to the exercise of, any U.K. Bail-in Power by the relevant U.K. resolution authority. See “Consent to U.K. Bail-in Power” on page 5 of this document. |
|
(terms continued on the next page) |
Commissions and initial issue price: |
Initial issue price(1) |
Price to public(1) |
Agent’s commissions |
Proceeds to issuer |
Per security |
$1,000 |
$1,000 |
$16.364(2)
$3.636(3) |
$980.00 |
Total |
$ |
$ |
$ |
$ |
|
|
|
|
|
| (1) | Our estimated value of the securities on the pricing date, based on our internal pricing models, is expected to be between $882.70
and $962.70 per security. The estimated value is expected to be less than the initial issue price of the securities. See “Additional
Information Regarding Our Estimated Value of the Securities” on page 4 of this document. |
| (2) | Morgan Stanley Wealth Management and its financial advisors will collectively receive from the agent, Barclays Capital Inc., a
fixed sales commission of $16.364 for each security they sell. See “Supplemental Plan of Distribution” in this document. |
| (3) | Reflects a structuring fee payable to Morgan Stanley Wealth Management by the agent or its affiliates of $3.636 for each security. |
One or more of our affiliates may purchase up to 15% of the aggregate
principal amount of the securities and hold such securities for investment for a period of at least 30 days. Accordingly, the total principal
amount of the securities may include a portion that was not purchased by investors on the original issue date. Any unsold portion held
by our affiliate(s) may affect the supply of securities available for secondary trading and, therefore, could adversely affect the price
of the securities in the secondary market. Circumstances may occur in which our interests or those of our affiliates could be in conflict
with your interests.
Investing in the securities involves risks not associated
with an investment in conventional debt securities. See “Risk Factors” beginning on page 14 of this document and beginning
on page S-9 of the prospectus supplement. You should read this document together with the related prospectus, prospectus supplement and
underlying supplement, each of which can be accessed via the hyperlinks below, before you make an investment decision.
The securities will not be listed on any U.S. securities exchange
or quotation system. Neither the U.S. Securities and Exchange Commission (the “SEC”) nor any state securities commission
has approved or disapproved of the securities or determined that this document is truthful or complete. Any representation to the contrary
is a criminal offense.
The securities constitute
our unsecured and unsubordinated obligations. The securities are not deposit liabilities of Barclays Bank PLC and are not covered by
the U.K. Financial Services Compensation Scheme or insured by the U.S. Federal Deposit Insurance Corporation or any other governmental
agency or deposit insurance agency of the United States, the United Kingdom or any other jurisdiction.
Prospectus
dated May 15, 2025 |
Prospectus Supplement
dated May 15, 2025 |
Underlying Supplement dated May 15, 2025 |

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
Terms continued from previous page: |
Optional early redemption: |
On any contingent payment date (other than the final contingent payment date), we will have the right to redeem the securities, in whole, but not in part, at our discretion, for the early redemption payment. If we elect to redeem the securities on any contingent payment date, we will give notice to the trustee on or before the immediately preceding determination date. Any early redemption of the securities will be at our discretion and will not automatically occur based on the performance of the underliers. No further payments will be made on the securities after they have been redeemed. |
Early redemption payment: |
The early redemption payment will be an amount per security equal to (i) the stated principal amount plus (ii) any contingent quarterly payment otherwise due. |
Final underlier value: |
With respect to each underlier, the closing level of that underlier on the final determination date |
Underlier performance factor: |
With respect to each underlier, its final underlier value divided by its initial underlier value |
Worst performing underlier: |
The underlier with the lowest underlier performance factor |
Determination dates†: |
September 29, 2025, December 29, 2025, March 27, 2026, June 29, 2026, September 28, 2026, December 28, 2026, March 30, 2027, June 28, 2027, September 27, 2027, December 27, 2027, March 27, 2028, June 27, 2028, September 27, 2028, December 27, 2028, March 27, 2029, June 27, 2029, September 27, 2029, December 27, 2029, March 27, 2030 and June 27, 2030. We also refer to June 27, 2030 as the final determination date. |
Contingent payment dates†: |
October 2, 2025, January 2, 2026, April 1, 2026, July 2, 2026, October 1, 2026, December 31, 2026, April 2, 2027, July 1, 2027, September 30, 2027, December 30, 2027, March 30, 2028, June 30, 2028, October 2, 2028, January 2, 2029, April 2, 2029, July 2, 2029, October 2, 2029, January 2, 2030, April 1, 2030 and the maturity date |
Closing level: |
With respect to each underlier, closing level has the meaning set forth under “Reference Assets—Indices—Special Calculation Provisions” in the prospectus supplement. |
Calculation agent: |
Barclays Bank PLC |
Additional terms: |
Terms used in this document, but not defined herein, will have the meanings ascribed to them in the prospectus supplement. |
CUSIP / ISIN: |
06746CBS7 / US06746CBS70 |
Listing: |
The securities will not be listed on any securities exchange. |
Selected dealer: |
Morgan Stanley Wealth Management (“MSWM”) |
* |
The underliers and the terms of the
securities are subject to adjustment by the calculation agent and the maturity date may be accelerated, in each case under certain
circumstances as set forth in the accompanying prospectus supplement. See “Risk Factors—Risks Relating to the Underliers”
below. |
† |
Subject to postponement in certain circumstances,
as described under “Reference Assets—Indices—Market Disruption Events for Securities with an Equity Index as a
Reference Asset,” “Reference Assets—Least or Best Performing Reference Asset—Scheduled Trading Days and Market
Disruption Events for Securities Linked to the Reference Asset with the Lowest or Highest Return in a Group of Two or More Equity
Securities, Exchange-Traded Funds, Equity Indices and/or Equity Futures Indices” and “Terms of the Notes—Payment
Dates” in the accompanying prospectus supplement |
Barclays Capital Inc. |

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
Additional Terms of the Securities
You should read this document
together with the prospectus dated May 15, 2025, as supplemented by the prospectus supplement dated May 15, 2025 relating to our Global
Medium-Term Notes, Series A, of which the securities are a part, and the underlying supplement dated May 15, 2025. This document, together
with the documents listed below, contains the terms of the securities and supersedes all prior or contemporaneous oral statements as well
as any other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation,
sample structures, brochures or other educational materials of ours. You should carefully consider, among other things, the matters set
forth under “Risk Factors” in the prospectus supplement, as the securities involve risks not associated with conventional
debt securities. We urge you to consult your investment, legal, tax, accounting and other advisors before you invest in the securities.
You may access these documents
on the SEC website at www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC
website):
| § | Prospectus dated May 15, 2025:
http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm |
| § | Prospectus supplement dated May 15, 2025:
http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm |
| § | Underlying supplement dated May 15, 2025:
http://www.sec.gov/Archives/edgar/data/312070/000095010325006053/dp228705_424b2-underl.htm |
Our SEC file number is 1-10257
and our Central Index Key, or CIK, on the SEC website is 0000312070. As used in this document, “we,” “us” and
“our” refer to Barclays Bank PLC.
In connection with this offering,
Morgan Stanley Wealth Management is acting in its capacity as a selected dealer.

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
Additional Information Regarding Our Estimated Value
of the Securities
Our internal pricing models take into account a number of variables
and are based on a number of subjective assumptions, which may or may not materialize, typically including volatility, interest rates
and our internal funding rates. Our internal funding rates (which are our internally published borrowing rates based on variables, such
as market benchmarks, our appetite for borrowing and our existing obligations coming to maturity) may vary from the levels at which our
benchmark debt securities trade in the secondary market. Our estimated value on the pricing date is based on our internal funding rates.
Our estimated value of the securities might be lower if such valuation were based on the levels at which our benchmark debt securities
trade in the secondary market.
Our estimated value of the securities on the pricing date is expected
to be less than the initial issue price of the securities. The difference between the initial issue price of the securities and our estimated
value of the securities is expected to result from several factors, including any sales commissions expected to be paid to Barclays Capital
Inc. or another affiliate of ours, any selling concessions, discounts, commissions or fees expected to be allowed or paid to non-affiliated
intermediaries, the estimated profit that we or any of our affiliates expect to earn in connection with structuring the securities, the
estimated cost that we may incur in hedging our obligations under the securities, and estimated development and other costs that we may
incur in connection with the securities. These other costs will include a fee paid to LFT Securities, LLC, an entity in which an affiliate
of Morgan Stanley Wealth Management has an ownership interest, for providing certain electronic platform services with respect to this
offering.
Our estimated value on the pricing date is not a prediction of the price
at which the securities may trade in the secondary market, nor will it be the price at which Barclays Capital Inc. may buy or sell the
securities in the secondary market. Subject to normal market and funding conditions, Barclays Capital Inc. or another affiliate of ours
intends to offer to purchase the securities in the secondary market but it is not obligated to do so.
Assuming that all relevant factors remain constant after the pricing
date, the price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market, if any, and the value
that we may initially use for customer account statements, if we provide any customer account statements at all, may exceed our estimated
value on the pricing date for a temporary period expected to be approximately 40 days after the initial issue date of the securities because,
in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost of hedging our obligations under
the securities and other costs in connection with the securities that we will no longer expect to incur over the term of the securities.
We made such discretionary election and determined this temporary reimbursement period on the basis of a number of factors, which may
include the tenor of the securities and/or any agreement we may have with the distributors of the securities. The amount of our estimated
costs that we effectively reimburse to investors in this way may not be allocated ratably throughout the reimbursement period, and we
may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the initial issue date of the
securities based on changes in market conditions and other factors that cannot be predicted.
We urge you to read “Risk Factors” beginning on page
14 of this document.
You may revoke your offer to purchase the securities at any time
prior to the pricing date. We reserve the right to change the terms of, or reject any offer to purchase, the securities prior to their
pricing date. In the event of any changes to the terms of the securities, we will notify you and you will be asked to accept such changes
in connection with your purchase. You may also choose to reject such changes in which case we may reject your offer to purchase.

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
Consent to U.K. Bail-in Power
Notwithstanding and to the
exclusion of any other term of the securities or any other agreements, arrangements or understandings between us and any holder or beneficial
owner of the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial
owner of the securities acknowledges, accepts, agrees to be bound by and consents to the exercise of, any U.K. Bail-in Power by the relevant
U.K. resolution authority.
Under the U.K. Banking Act 2009,
as amended, the relevant U.K. resolution authority may exercise a U.K. Bail-in Power in circumstances in which the relevant U.K. resolution
authority is satisfied that the resolution conditions are met. These conditions include that a U.K. bank or investment firm is failing
or is likely to fail to satisfy the Financial Services and Markets Act 2000 (the “FSMA”) threshold conditions for authorization
to carry on certain regulated activities (within the meaning of section 55B FSMA) or, in the case of a U.K. banking group company that
is a European Economic Area (“EEA”) or third country institution or investment firm, that the relevant EEA or third country
relevant authority is satisfied that the resolution conditions are met in respect of that entity.
The U.K. Bail-in Power includes
any write-down, conversion, transfer, modification and/or suspension power, which allows for (i) the reduction or cancellation of all,
or a portion, of the principal amount of, or interest on, or any other amounts payable on, the securities; (ii) the conversion of all,
or a portion, of the principal amount of, or interest on, or any other amounts payable on, the securities into shares or other securities
or other obligations of Barclays Bank PLC or another person (and the issue to, or conferral on, the holder or beneficial owner of the
securities of such shares, securities or obligations); (iii) the cancellation of the securities and/or (iv) the amendment or alteration
of the maturity of the securities, or the amendment of the amount of interest or any other amounts due on the securities, or the dates
on which interest or any other amounts become payable, including by suspending payment for a temporary period; which U.K. Bail-in Power
may be exercised by means of a variation of the terms of the securities solely to give effect to the exercise by the relevant U.K. resolution
authority of such U.K. Bail-in Power. Each holder and beneficial owner of the securities further acknowledges and agrees that the rights
of the holders or beneficial owners of the securities are subject to, and will be varied, if necessary, solely to give effect to, the
exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority. For the avoidance of doubt, this consent and acknowledgment
is not a waiver of any rights holders or beneficial owners of the securities may have at law if and to the extent that any U.K. Bail-in
Power is exercised by the relevant U.K. resolution authority in breach of laws applicable in England.
For more information, please see
“Risk Factors—Risks Relating to the Issuer—You may lose some or all of your investment if any U.K. bail-in power is
exercised by the relevant U.K. resolution authority” in this document as well as “U.K. Bail-in Power,” “Risk Factors—Risks
Relating to the Securities Generally—Regulatory action in the event a bank or investment firm in the Group is failing or likely
to fail, including the exercise by the relevant U.K. resolution authority of a variety of statutory resolution powers, could materially
adversely affect the value of any securities” and “Risk Factors—Risks Relating to the Securities Generally—Under
the terms of the securities, you have agreed to be bound by the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority”
in the accompanying prospectus supplement.

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
Investment Summary
Contingent Income Callable Securities
Principal at Risk Securities
The Contingent Income Callable Securities due July 2, 2030 Based on
the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500®
Index, which we refer to as the securities, provide an opportunity for investors to receive a contingent quarterly payment, which is an
amount equal to at least $20.00 (at least 2.00% of the stated principal amount), with respect to each quarterly determination date on
which the closing level of each underlier is greater than or equal to 70% of its initial underlier value, which we refer to as a coupon
barrier level. However, if the closing level of any underlier is less than its coupon barrier level on a determination date, investors
will not receive any contingent quarterly payment for that determination date. The actual contingent quarterly payment will be determined
on the pricing date. The closing level of at least one of the underliers could be below its coupon barrier level on most or all of the
determination dates so that you receive few or no contingent quarterly payments over the term of the securities.
On any contingent payment date (other than the final contingent payment
date), we will have the right to redeem the securities at our discretion for an early redemption payment equal to the stated principal
amount plus any contingent quarterly payment otherwise due. If the securities are redeemed prior to maturity, investors will receive
no further contingent quarterly payments. Any early redemption of the securities will be at our discretion and will not automatically
occur based on the performance of the underliers. At maturity, if the securities have not previously been redeemed and the final underlier
value of each underlier is greater than or equal to 60% of its initial underlier value, which we refer to as a downside threshold level,
the payment at maturity will be equal to the stated principal amount plus any contingent quarterly payment otherwise due. However,
if the securities have not previously been redeemed and the final underlier value of any underlier is less than its downside threshold
level, investors will lose 1% of the stated principal amount for every 1% that the final underlier value of the worst performing underlier
is less than its initial underlier value. Under these circumstances, the amount investors receive will be less than 60% of the stated
principal amount and could be zero. Investors in the securities must be willing and able to accept the risk of losing their entire initial
investment based on the performance of the worst performing underlier and also the risk of not receiving any contingent quarterly payment
throughout the entire term of the securities. In addition, investors will not participate in any appreciation of any underlier.

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
Key Investment Rationale
The securities are for investors who are willing and able to risk their
principal and forgo guaranteed interest payments, in exchange for the opportunity to potentially receive contingent quarterly payments
at an above-market rate, subject to early redemption at our discretion. The securities offer investors an opportunity to receive a contingent
quarterly payment of at least $20.00 (at least 2.00% of the stated principal amount) with respect to each determination date on which
the closing level of each underlier is greater than or equal to its coupon barrier level. The actual contingent quarterly payment will
be determined on the pricing date. In addition, the following scenarios reflect the potential payment on the securities, if any, upon
an early redemption or at maturity:
Scenario 1 |
On any contingent payment date (other than the
final contingent payment date), we redeem the securities.
§ The
securities will be redeemed for (i) the stated principal amount plus (ii) any contingent quarterly payment otherwise due.
§ Investors
will not participate in any appreciation of any underlier from its initial underlier value and will receive no further contingent quarterly
payments.
Any early redemption of the securities will be at our discretion
and will not automatically occur based on the performance of the underliers. It is more likely that we will redeem the securities when
it would otherwise be advantageous for you to continue to hold the securities. As such, we will be more likely to redeem the securities
when the expected interest payable on the securities is greater than the interest that would be payable on other instruments of a comparable
maturity and credit rating trading in the market. In other words, we will be more likely to redeem the securities when the securities
are paying an above-market coupon. If the securities are redeemed prior to maturity, no further contingent quarterly payments will be
made on the securities and you may be forced to reinvest in a lower interest rate environment. There is no guarantee that you would be
able to reinvest the proceeds from an investment in the securities in a comparable investment with a similar level of risk in the event
the securities are redeemed prior to the maturity date. On the other hand, we will be less likely to exercise our redemption
right when the expected interest payable on the securities is less than the interest that would be payable on other instruments of a
comparable maturity and credit rating trading in the market. Under these circumstances, it is also more likely that you will receive
few or no contingent quarterly payments and that you will suffer a significant loss on your investment at maturity. |
Scenario 2 |
The securities are not redeemed prior to maturity
and the final underlier value of each underlier is greater than or equal to its downside threshold level.
§ The
payment due at maturity will be (i) the stated principal amount plus (ii) any contingent quarterly payment otherwise due.
§ Investors
will not participate in any appreciation of any underlier from its initial underlier value. |
Scenario 3 |
The securities are not redeemed prior to maturity
and the final underlier value of any underlier is less than its downside threshold level.
§
The payment due at maturity will be equal to the stated principal amount times the underlier performance factor of the worst
performing underlier. In this case, at maturity, the securities pay less than 60% of the stated principal amount and the percentage
loss of the stated principal amount will be equal to the percentage decrease in the final underlier value of the worst performing
underlier from its initial underlier value. For example, if the final underlier value of the worst performing underlier is 55%
less than its initial underlier value, the securities will pay $450.00 per security, or 45% of the stated principal amount, for a
loss of 55% of the stated principal amount. Investors will lose a significant portion and may lose all of their principal in
this scenario. |

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
Selected Purchase
Considerations
The securities
are not appropriate for all investors. The securities may be an appropriate investment for you if all of the following statements
are true:
| § | You do not seek an investment that produces fixed
periodic interest or coupon payments or other non-contingent sources of current income. |
| § | You do not anticipate that the final underlier value
of any underlier will be less than its downside threshold level on the final determination date, and you are willing and able to
accept the risk that, if it is, you
will lose a significant portion or all of the stated principal amount. |
| § | You do not anticipate that the closing level of any
underlier will be less than its coupon barrier level on any determination date, and you are willing and able to accept the risk that,
if it is, you may receive few or
no contingent quarterly payments over the term of the securities. |
| § | You are willing and able to accept the individual
market risk of each underlier and you understand that poor performance by any underlier over the term of the securities
may negatively affect your return and will not be offset or mitigated by any positive performance by the other underliers. |
| § | You are willing and able to forgo participation in
any appreciation of any underlier,
and you understand that any return on your investment will be limited to the contingent quarterly payments that may be payable on the
securities. |
| § | You are willing and able to accept the risks associated
with an investment linked to the performance of the worst performing
of the underliers, as explained in more detail in the “Risk Factors” section of this document. |
| § | You understand and accept that you will not be entitled
to receive dividends or distributions that may be paid to holders of the securities composing the underliers, nor will you have any voting
rights with respect to the securities composing the underliers. |
| § | You are willing and able to accept the risk that
we may redeem the securities at our discretion prior to scheduled maturity, that it is more likely that we will redeem the securities
when it would otherwise be advantageous for you to continue to hold the securities and that you may not be able to reinvest your money
in an alternative investment with comparable risk and yield. |
| § | You do not seek an investment for which there will
be an active secondary market and you are willing and able to hold the securities to maturity if the securities are not redeemed at our
discretion. |
| § | You are willing and able to assume our credit risk
for all payments on the securities. |
| § | You are willing and able to consent to the exercise
of any U.K. Bail-in Power by any relevant U.K. resolution authority. |
The securities
may not be an appropriate investment for you if any of the following statements are true:
| § | You seek an investment that produces fixed periodic
interest or coupon payments or other non-contingent sources of current income. |
| § | You seek an investment that provides for the full
repayment of principal at maturity. |
| § | You anticipate that the final underlier value of
any underlier
will be less than its downside threshold level on the final determination date, or you are unwilling or unable to accept the risk that,
if it is, you will lose a significant portion or all of the stated principal amount. |
| § | You anticipate that the closing level of any
underlier will be less than its coupon barrier
level on one or more determination dates, or you are unwilling or unable to accept the risk that, if it is,
you may receive few or no contingent quarterly payments over the term of the securities. |
| § | You are unwilling or unable to accept the individual
market risk of each underlier or the risk that poor performance by any
underlier over the term of the securities may negatively
affect your return and will not be offset or mitigated by any positive performance by the other underliers. |
| § | You seek exposure to any upside performance of the
underliers or you seek an investment with a return that is not limited to the contingent quarterly payments that may be payable on the
securities. |
| § | You are unwilling or unable to accept the risks associated
with an investment linked to the performance of the worst performing
of the underliers, as explained in more detail in the “Risk Factors” section of this document. |
| § | You seek an investment that entitles you to dividends
or distributions on, or voting rights related to, the securities composing the underliers. |
| § | You are unwilling or unable to accept the risk that
we may redeem the securities at our discretion prior to scheduled maturity. |
| § | You seek an investment for which there will be an
active secondary market and/or you are unwilling or unable to hold the securities to maturity if they are not redeemed at our discretion.
|
| § | You are unwilling or unable to assume our credit
risk for all payments on the securities. |
| § | You are unwilling or unable to consent to the exercise
of any U.K. Bail-in Power by any relevant U.K. resolution authority. |
You must rely on your own
evaluation of the merits of an investment in the securities. You should reach a decision whether to invest in the securities after
carefully considering, with your advisors, the appropriateness of the securities in light of your investment

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
objectives and the specific information
set forth in this document, the prospectus, the prospectus supplement and the underlying supplement. Neither the issuer nor Barclays Capital
Inc. makes any recommendation as to the appropriateness of the securities for investment.

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
How the Securities Work
The following diagrams illustrate the potential outcomes for the securities
depending on whether we exercise our option to redeem the securities and on the closing level of each underlier on the determination dates.
Diagram #1: Contingent Payment Dates Prior to the
Maturity Date

Diagram #2: Payment at Maturity If Not Redeemed Early
at Our Option

For more information about the payment upon an early redemption or
at maturity in different hypothetical scenarios, see “Hypothetical Examples” below.

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
Hypothetical Examples
The numbers appearing in the following examples may have been rounded
for ease of analysis. The examples below assume that the securities will be held until maturity or earlier redemption and do not take
into account the tax consequences of an investment in the securities. The examples below are based on the following terms:*
Hypothetical Initial Underlier Values: |
With respect to each underlier: 100.00 |
Hypothetical Coupon Barrier Levels: |
With respect to each underlier: 70.00, which is 70% of its hypothetical initial underlier value |
Hypothetical Downside Threshold Levels: |
With respect to each underlier: 60.00, which is 60% of its hypothetical initial underlier value |
Hypothetical Contingent Quarterly Payment: |
$20.00 (2.00% of the stated principal amount). The actual contingent quarterly payment will be set on the pricing date and will be at least 2.00% of the stated principal amount. |
Stated Principal Amount: |
$1,000 per security |
* Terms used for purposes of these hypothetical examples may not represent
the actual initial underlier values, coupon barrier levels, downside threshold levels or contingent quarterly payment applicable to the
securities. In particular, the hypothetical initial underlier value of 100.00 for each underlier used in these examples has been chosen
for illustrative purposes only and may not represent a likely actual initial underlier value for any underlier. Please see “MSCI
EAFE® Index Overview,” “Russell 2000® Index Overview” and “S&P 500®
Index Overview” below for recent actual values of the underliers. The actual initial underlier values, coupon barrier levels, downside
threshold levels and contingent quarterly payment applicable to the securities will be determined on the pricing date.
The examples below are based on the worst performing underlier as of
each determination date. We make no representation or warranty as to which of the underliers will be the worst performing underlier for
the purpose of calculating the payment at maturity, if applicable, or as to what the closing level of any underlier will be on any determination
date. For purposes of the examples below, the “worst performing underlier” on any determination date will be the underlier
with the largest percentage decline from its initial underlier value to its closing level on that determination date.
In Examples 1 and 2, we redeem the securities on one of the contingent
payment dates prior to the final contingent payment date. In Examples 3 and 4, the securities are not redeemed prior to, and remain outstanding
until, maturity. Any early redemption of the securities will be at our discretion and will not automatically occur based on the performance
of the underliers.

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
|
Example 1 |
Example 2 |
Determination
Dates |
Hypothetical
Closing Level of the Worst Performing Underlier |
Contingent Quarterly Payment (per security) |
Early Redemption Payment (per
security) |
Hypothetical
Closing Level of the Worst Performing Underlier |
Contingent
Quarterly Payment (per security) |
Early
Redemption
Payment (per security) |
#1 |
65.00 |
$0 |
N/A |
110.00 |
$20.00 |
N/A |
#2 |
125.00 |
—* |
$1,020.00 |
50.00 |
$0 |
N/A |
#3 |
N/A |
N/A |
N/A |
65.00 |
$0 |
N/A |
#4 |
N/A |
N/A |
N/A |
68.00 |
$0 |
N/A |
#5 |
N/A |
N/A |
N/A |
90.00 |
$20.00 |
N/A |
#6 |
N/A |
N/A |
N/A |
85.00 |
$20.00 |
N/A |
#7 |
N/A |
N/A |
N/A |
65.00 |
$0 |
N/A |
#8 |
N/A |
N/A |
N/A |
95.00 |
$20.00 |
N/A |
#9 |
N/A |
N/A |
N/A |
80.00 |
$20.00 |
N/A |
#10 |
N/A |
N/A |
N/A |
55.00 |
$0 |
$1,000.00 |
#11 to #19 |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Final Determination Date |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Payment at Maturity |
N/A |
N/A |
* If we redeem the securities, the early redemption payment will include
any contingent quarterly payment otherwise due.
In Example 1, we redeem the securities on the contingent payment date
following the second determination date. As the closing level of each underlier on the second determination date is greater than or equal
to its coupon barrier level, the early redemption payment you receive following the second determination date will include the contingent
quarterly payment due with respect to that determination date, and the early redemption payment will be calculated as follows:
stated principal
amount + contingent quarterly payment = $1,000 + $20.00 = $1,020.00
In this example, the optional early redemption feature limits the
term of your investment to approximately 6 months and you may not be able to reinvest at comparable terms or returns. If the securities
are redeemed early, you will stop receiving contingent quarterly payments. Further, although the worst performing underlier has appreciated
by 25% from its initial underlier value as of the second determination date, upon early redemption, you receive only $1,020.00 per security
and do not benefit from the appreciation of any underlier.
In Example 2, we redeem the securities on the contingent payment date
following the tenth determination date. As the closing levels of each underlier on the first, fifth, sixth, eighth and ninth determination
dates are greater than or equal to its coupon barrier level, you receive the contingent quarterly payment of $20.00 with respect to those
determination dates. However, because the closing level of at least one underlier is below its coupon barrier level on the tenth determination
date, the early redemption payment you receive following the tenth determination date will not include any contingent quarterly payment
with respect to that determination date, and the early redemption payment will be equal to the stated principal amount of $1,000 per security.
In this example, the optional early redemption feature limits the
term of your investment to approximately 30 months and you may not be able to reinvest at comparable terms or returns. If the securities
are redeemed early, you will stop receiving contingent quarterly payments.

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
|
Example 3 |
Example 4 |
Determination
Dates |
Hypothetical
Closing Level of the Worst Performing Underlier |
Contingent Quarterly Payment (per security) |
Early Redemption Payment (per
security) |
Hypothetical
Closing Level of the Worst Performing Underlier |
Contingent
Quarterly Payment (per security) |
Early
Redemption
Payment (per security) |
#1 |
65.00 |
$0 |
N/A |
40.00 |
$0 |
N/A |
#2 |
67.00 |
$0 |
N/A |
55.00 |
$0 |
N/A |
#3 |
60.00 |
$0 |
N/A |
52.50 |
$0 |
N/A |
#4 |
55.00 |
$0 |
N/A |
60.00 |
$0 |
N/A |
#5 |
45.00 |
$0 |
N/A |
63.00 |
$0 |
N/A |
#6 |
40.00 |
$0 |
N/A |
55.00 |
$0 |
N/A |
#7 |
45.00 |
$0 |
N/A |
60.00 |
$0 |
N/A |
#8 |
55.00 |
$0 |
N/A |
50.00 |
$0 |
N/A |
#9 |
62.50 |
$0 |
N/A |
40.00 |
$0 |
N/A |
#10 |
50.00 |
$0 |
N/A |
62.50 |
$0 |
N/A |
#11 to #19 |
Various (below coupon barrier level) |
$0 |
N/A |
Various (below coupon barrier level) |
$0 |
N/A |
Final Determination Date |
50.00 |
$0 |
N/A |
65.00 |
$0 |
N/A |
Payment at Maturity |
$500.00 |
$1,000.00 |
Examples 3 and 4 illustrate the payment at maturity per security based
on the final underlier value of the worst performing underlier.
In Example 3, the securities are not redeemed prior to maturity and
the closing level of at least one underlier is below its coupon barrier level on each determination date throughout the term of the securities.
As a result, you do not receive any contingent quarterly payments during the term of the securities even if the closing levels of the
other underliers on any of the determination dates have appreciated or have not declined below their respective coupon barrier levels.
In addition, because the final underlier value of the worst performing underlier is less than its downside threshold level, at maturity,
your initial investment is fully exposed to the decline in the closing level of the worst performing underlier. Thus, investors will receive
a cash payment at maturity that is significantly less than the stated principal amount, calculated as follows:
($1,000 ×
underlier performance factor of the worst performing underlier)
= $1,000
× (final underlier value of the worst performing underlier / initial underlier value
of the worst performing underlier)
= $1,000 ×
(50.00 / 100.00) = $500.00
In this example, the cash payment you receive at maturity is significantly
less than the stated principal amount.
In Example 4, the securities are not redeemed prior to maturity and
the closing level of at least one underlier is below its coupon barrier level on each of
the determination dates prior to the final determination date. As a result, you do not receive any contingent quarterly payments following
those determination dates, even if the closing levels of the other underliers on those determination dates have appreciated or have not
declined below their respective coupon barrier levels. In addition, the closing level of the worst performing underlier decreases to a
final underlier value of 65.00. Although the final underlier value of the worst performing underlier is less than its initial underlier
value, because the final underlier value of the worst performing underlier is still not less than its downside threshold level, you receive
the stated principal amount at maturity. However, because the final underlier value of the worst performing underlier is less than its
coupon barrier level, you will not receive a contingent quarterly payment with respect to the final determination date.
In this example, although the final underlier value of the worst
performing underlier represents a decline of 35% from its initial underlier value, you receive the stated principal amount of $1,000 per
security at maturity because the final underlier value of the worst performing underlier is not less than its downside threshold level.

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
Risk Factors
An investment in the securities involves significant risks. We urge
you to consult your investment, legal, tax, accounting and other advisors before you invest in the securities. Investing in the securities
is not equivalent to investing directly in any or all of the underliers or the securities composing the underliers. Some of the risks
that apply to an investment in the securities are summarized below, but we urge you to read the more detailed explanation of risks relating
to the securities generally in the “Risk Factors” section of the prospectus supplement. You should not purchase the securities
unless you understand and can bear the risks of investing in the securities.
Risks Relating to the Securities Generally
| § | The securities do not guarantee the return of any principal.
The terms of the securities differ from those of ordinary debt securities in that the securities do not guarantee the return of any
of the stated principal amount at maturity. Instead, if the securities have not been redeemed prior to maturity and if the final underlier
value of any underlier is less than its downside threshold level, you will be exposed to the decline in the closing level of the worst
performing underlier, as compared to its initial underlier value, on a 1-to-1 basis and you will receive for each security that you hold
at maturity an amount in cash equal to the stated principal amount times the underlier performance factor of the worst performing
underlier. Under these circumstances, your payment at maturity will be less than 60% of the stated principal amount and could be zero. |
| § | You will not receive any contingent quarterly payment
for any quarterly period where the closing level of any underlier on the applicable determination date is less than its coupon barrier
level. The terms of the securities differ from those of ordinary debt securities in that they do not provide for regular interest
payments. Instead, a contingent quarterly payment will be made with respect to a quarterly period only if the closing level of each underlier
is greater than or equal to its coupon barrier level on the related determination date. If the closing level of any underlier is below
its coupon barrier level on any determination date, you will not receive a contingent quarterly payment for the related quarterly period.
The closing level of any underlier could be below its coupon barrier level on most or all of the determination dates so that you receive
few or no contingent quarterly payments over the term of the securities. If you do not receive sufficient contingent quarterly payments
over the term of the securities, the overall return on the securities may be less than the amount that would be paid on a conventional
debt security of the issuer of comparable maturity. |
| § | You will not participate in any appreciation in the value
of any underlier. You will not participate in any appreciation in the value of any underlier from its initial underlier value even
though you will be exposed to the depreciation in the value of the worst performing underlier if the securities have not been redeemed
prior to maturity and the final underlier value of the worst performing underlier is less than its downside threshold level. The return
on the securities will be limited to the contingent quarterly payment that is paid with respect to each determination date on which the
closing level of each underlier is greater than or equal to its coupon barrier level. |
| § | You are exposed to the market risk of each underlier,
with respect to both the contingent quarterly payments, if any, and the payment at maturity, if any. Your return on the securities
is not linked to a basket consisting of each underlier. Rather, it will be contingent upon the independent performance of each underlier.
Unlike an instrument with a return linked to a basket of underlying assets in which risk is mitigated and diversified among all the components
of the basket, you will be exposed to the risks related to each underlier. Poor performance by any underlier over the term of the securities
may negatively affect your return and will not be offset or mitigated by any positive performance by the other underliers. To receive
any contingent quarterly payments, each underlier must close at or above its coupon barrier level on the applicable determination date.
In addition, if the securities have not been redeemed early and any underlier has declined to below its downside threshold level as of
the final determination date, you will be fully exposed to the decline in the worst performing underlier over the term of the securities
on a 1-to-1 basis, even if the other underliers have appreciated or have not declined as much. Under this scenario, the value of any such
payment will be less than 60% of the stated principal amount and could be zero. Accordingly, your investment is subject to the market
risk of each underlier. |
| § | Because the securities are linked to the performance of
the worst performing underlier, you are exposed to greater risks of no contingent quarterly payments and sustaining a significant loss
on your investment than if the securities were linked to just one underlier. The risk that you will not receive any contingent quarterly
payments, or that you will suffer a significant loss on your investment, is greater if you invest in the securities as opposed to substantially
similar securities that are linked to the performance of just one underlier. With three underliers, it is more likely that any underlier
will close below its coupon barrier level on any determination date or its downside threshold level on the final determination date than
if the securities were linked to only one underlier, and therefore it is more likely that you will not receive any contingent quarterly
payments and that you will suffer a significant loss on your investment. |
| § | Early redemption risk. The term of your investment
in the securities may be limited to as short as approximately three months by the optional early redemption feature of the securities.
Any early redemption of the securities will be at our discretion and will not automatically occur based on the performance of the underliers.
It is more likely that we will redeem the securities when it would otherwise be advantageous for you to continue to hold the securities.
As such, we will be more likely to redeem the securities when the expected interest payable on the securities is greater than the interest
that would be payable on other instruments of a |

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
comparable maturity and credit rating trading in the market.
In other words, we will be more likely to redeem the securities when the securities are paying an above-market coupon. If the securities
are redeemed prior to maturity, no further contingent quarterly payments will be made on the securities and you may be forced to reinvest
in a lower interest rate environment. There is no guarantee that you would be able to reinvest the proceeds from an investment in the
securities in a comparable investment with a similar level of risk in the event the securities are redeemed prior to the maturity date. On
the other hand, we will be less likely to exercise our redemption right when the expected interest payable on the securities is less than
the interest that would be payable on other instruments of a comparable maturity and credit rating trading in the market. Under these
circumstances, it is also more likely that you will receive few or no contingent quarterly payments and that you will suffer a significant
loss on your investment at maturity.
| § | Any payment on the securities will be determined based
on the closing levels of the underliers on the dates specified. Any payment on the securities will be determined based on the closing
levels of the underliers on the dates specified. You will not benefit from any more favorable values of the underliers determined at any
other time. |
| § | Contingent repayment of principal applies only at maturity
or upon any early redemption. You should be willing and able to hold the securities to maturity or any early redemption. If you sell
the securities prior to maturity in the secondary market, if any, you may have to sell the securities at a loss relative to your initial
investment even if the level of each underlier is above its downside threshold level. |
| § | The securities
are subject to volatility risk. Volatility
is a measure of the degree of variation in the levels of the underliers over a period of time. The contingent quarterly payment is determined
based on a number of factors, including the expected volatility of the underliers. The contingent quarterly payment is higher than the
fixed rate that we would pay on a conventional debt security of the same tenor and is higher than it otherwise would be if the level of
expected volatility of the underliers taken into account in determining the terms of the securities were lower. As volatility of an underlier
increases, there will typically be a greater likelihood that (a) the closing level of that underlier will be less than its coupon barrier
level on one or more determination dates and (b) the final underlier value of that underlier will be less than its downside threshold
level. |
Accordingly, you should understand that a higher contingent
quarterly payment reflects, among other things, an indication of a greater likelihood that you will (a) not receive contingent quarterly
payments with respect to one or more determination dates and/or (b) incur a loss of principal at maturity than would have been the case
had the contingent quarterly payment been lower. In addition, actual volatility over the term of the securities may be significantly higher
than the expected volatility at the time the terms of the securities were determined. If actual volatility is higher than expected, you
will face an even greater risk that you will not receive contingent quarterly payments and/or that you will lose a significant portion
or all of your principal at maturity for the reasons described above.
| § | Investing in the securities is not equivalent to investing
in any or all underliers or the securities composing the underliers. Investors in the securities will not have voting rights
or rights to receive dividends or other distributions or any other rights with respect to the securities composing the underliers. |
| § | Tax treatment. Significant
aspects of the tax treatment of the securities are uncertain. You should consult your tax advisor about your tax situation. See “Additional
provisions—Tax considerations” below. |
Risks Relating to the Issuer
| § | Credit of issuer. The securities are unsecured and
unsubordinated debt obligations of the issuer, Barclays Bank PLC, and are not, either directly or indirectly, an obligation of any third
party. Any payment to be made on the securities, including any repayment of principal, is subject to the ability of Barclays Bank PLC
to satisfy its obligations as they come due and is not guaranteed by any third party. As a result, the actual and perceived creditworthiness
of Barclays Bank PLC may affect the market value of the securities and, in the event Barclays Bank PLC were to default on its obligations,
you might not receive any amount owed to you under the terms of the securities. |
| § | You may
lose some or all of your investment if any U.K. Bail-in Power is exercised by the relevant U.K.
resolution authority.
Notwithstanding and to the exclusion of any other term of the securities or any other agreements, arrangements or understandings between
Barclays Bank PLC and any holder or beneficial owner of the securities (or the trustee on behalf of the holders of the securities), by
acquiring the securities, each holder or beneficial owner of the securities acknowledges, accepts, agrees to be bound by, and consents
to the exercise of, any U.K. Bail-in Power by the relevant U.K. resolution authority as set forth under “Consent to U.K. Bail-in
Power” in this document. Accordingly, any U.K. Bail-in Power may be exercised in such a manner as to result in you and other holders
and beneficial owners of the securities losing all or a part of the value of your investment in the securities or receiving a different
security from the securities, which may be worth significantly less than the securities and which may have significantly fewer protections
than those typically afforded to debt securities. Moreover, the relevant U.K. resolution authority may exercise the U.K. Bail-in Power
without providing any advance notice to, or requiring the consent of, the holders and beneficial owners of the securities. The exercise
of any U.K. Bail-in Power by the relevant U.K. resolution authority with respect to the securities will not be a default or an Event of
Default (as each term is defined in the senior debt securities indenture) and the trustee will not be liable for any action that the trustee
takes, or abstains from taking, in either case, in accordance with the exercise of the U.K. Bail-in Power by the relevant U.K. resolution
authority with respect to the securities. See “Consent to U.K. Bail-in |

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
Power” in this
document as well as “U.K. Bail-in Power,” “Risk Factors—Risks Relating to the Securities Generally—Regulatory
action in the event a bank or investment firm in the Group is failing or likely to fail, including the exercise by the relevant U.K. resolution
authority of a variety of statutory resolution powers, could materially adversely affect the value of any securities” and “Risk
Factors—Risks Relating to the Securities Generally—Under the terms of the securities, you have agreed to be bound by the exercise
of any U.K. Bail-in Power by the relevant U.K. resolution authority” in the accompanying prospectus supplement.
Risks Relating to the Underliers
| § | Adjustments to the underliers could adversely affect the value of the securities. The sponsor of an underlier may add, delete,
substitute or adjust the securities composing that underlier or make other methodological changes to that underlier that could affect
its performance. The calculation agent will calculate the value to be used as the closing level of an underlier in the event of certain
material changes in or modifications to that underlier. In addition, the sponsor of an underlier may also discontinue or suspend calculation
or publication of that underlier at any time. Under these circumstances, the calculation agent may select a successor index that the calculation
agent determines to be comparable to the discontinued underlier or, if no successor index is available, the calculation agent will determine
the value to be used as the closing level of that underlier. Any of these actions could adversely affect the value of the relevant underlier
and, consequently, the value of the securities. See “Reference Assets—Indices—Adjustments Relating to Securities with
an Index as a Reference Asset” in the accompanying prospectus supplement. |
| § | Governmental legislative or regulatory actions, such as sanctions, could adversely affect your investment in the securities.
Governmental legislative or regulatory actions, including, without limitation, sanctions-related actions by the U.S. or a foreign government,
could prohibit or otherwise restrict persons from holding the securities or securities included in any underlier, or engaging in transactions
in them, and any such action could adversely affect the value of that underlier. These legislative or regulatory actions could result
in restrictions on the securities. You may lose a significant portion or all of your initial investment in the securities if you are forced
to divest the securities due to government mandates, especially if such divestment must be made at a time when the value of the securities
has declined. |
| § | We may accelerate the securities if a change-in-law event
occurs. Upon the occurrence of legal or regulatory changes that may, among other things, prohibit or otherwise materially restrict
persons from holding the securities or an underlier or its components, or engaging in transactions in them, the calculation agent may
determine that a change-in-law event has occurred and accelerate the maturity date for a payment determined by the calculation agent in
its sole discretion. Any amount payable upon acceleration could be significantly less than any amount that would be due on the securities
if they were not accelerated. However, if the calculation agent elects not to accelerate the securities, the value of, and any amount
payable on, the securities could be adversely affected, perhaps significantly, by the occurrence of those legal or regulatory changes.
See “Terms of the Notes—Change-in-Law Events” in the accompanying prospectus supplement. |
| § | The securities are subject to small-capitalization companies
risk with respect to the RTY Index. The RTY Index tracks companies that are considered small-capitalization companies. These companies
often have greater stock price volatility, lower trading volume and less liquidity than large-capitalization companies, and therefore
securities linked to the RTY Index may be more volatile than an investment linked to an index with component stocks issued by large-capitalization
companies. Stock prices of small-capitalization companies are also more vulnerable than those of large-capitalization companies to adverse
business and economic developments. In addition, small-capitalization companies are typically less stable financially than large-capitalization
companies and may depend on a small number of key personnel, making them more vulnerable to loss of personnel. Small-capitalization companies
are often subject to less analyst coverage and may be in early, and less predictable, periods of their corporate existences. Such companies
tend to have smaller revenues, less diverse product lines, smaller shares of their product or service markets, fewer financial resources
and less competitive strengths than large-capitalization companies and are more susceptible to adverse developments related to their products. |
| § | There are risks associated with investments in securities
linked to the value of non-U.S. equity securities in non-U.S. securities markets with respect to the MXEA Index. The equity securities
composing the MXEA Index are issued by non-U.S. companies in non-U.S. securities markets. Investments in securities linked to the value
of such non-U.S. equity securities involve risks associated with the securities markets in the home countries of the issuers of those
non-U.S. equity securities, including risks of volatility in those markets, governmental intervention in those markets and cross shareholdings
in companies in certain countries. Also, there is generally less publicly available information about companies in some of these jurisdictions
than there is about U.S. companies that are subject to the reporting requirements of the SEC, and generally non-U.S. companies are subject
to accounting, auditing and financial reporting standards and requirements and securities trading rules different from those applicable
to U.S. reporting companies. The prices of securities in non-U.S. markets may be affected by political, economic, financial and social
factors in those countries, or global regions, including changes in government, economic and fiscal policies and currency exchange laws. |
| § | The level of the MXEA Index is subject to currency exchange
risk with respect to the U.S. dollar and the non-U.S. currencies represented in the MXEA Index. Because the securities composing the
MXEA Index are denominated in non-U.S. currencies and are converted into U.S. dollars for purposes of calculating the level of the MXEA
Index, the level of the MXEA Index will be exposed to the currency exchange rate risk with respect to each of those non-U.S. currencies
relative to the U.S. dollar. An investor’s net exposure will depend on the extent to which each of those non-U.S. currencies strengthens
or weakens against the U.S. dollar and the relative weight of the securities denominated in those non-U.S. currencies. If, taking into
account the relevant |

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
weighting, the U.S. dollar strengthens against those non-U.S.
currencies, the level of the MXEA Index will be adversely affected and any payments on the securities determined based in part on the
MXEA Index may be reduced.
Exchange rate movements for a particular currency are volatile
and are the result of numerous factors, including the supply of, and the demand for, those currencies, as well as government policy, intervention
or actions, but are also influenced significantly from time to time by political or economic developments, and by macroeconomic factors
and speculative actions related to the relevant region. Of particular importance to potential currency exchange risk are:
| o | existing and expected rates of inflation; |
| o | existing and expected interest rate levels; |
| o | the balance of payments between the countries represented in the MXEA Index and the United States; and |
| o | the extent of governmental surpluses or deficits in the countries represented in the MXEA Index and the United States. |
All of these factors are in turn sensitive to the monetary,
fiscal and trade policies pursued by the governments of the countries represented in the MXEA Index, the United States and other countries
important to international trade and finance.
Risks Relating to Conflicts of Interest
| § | Hedging and trading activity by the issuer and its affiliates
could potentially adversely affect the value of the securities. Hedging or trading activities of the issuer’s affiliates and
of any other hedging counterparty with respect to the securities could adversely affect the values of the underliers and, as a result,
could decrease the amount an investor may receive on the securities at maturity, if any. Any of these hedging or trading activities on
or prior to the pricing date could potentially increase the initial underlier values and, as a result, the coupon barrier levels, which
are the levels at or above which the respective underliers must close on each determination date in order for you to receive a contingent
quarterly payment or, if the securities are not redeemed prior to maturity, the downside threshold levels, which are the levels at or
above which the respective underliers must close on the final determination date in order for you to avoid being exposed to the negative
performance of the worst performing underlier at maturity. Additionally, such hedging or trading activities during the term of the securities
could potentially affect the values of the underliers on the determination dates and, accordingly, whether investors will receive one
or more contingent quarterly payments and, if the securities are not redeemed prior to maturity, the payment at maturity, if any. |
| § | We and our affiliates, and any dealer participating in
the distribution of the securities, may engage in various activities or make determinations that could materially affect your securities
in various ways and create conflicts of interest. We and our affiliates play a variety of roles in connection with the issuance of
the securities, as described below. In performing these roles, our and our affiliates’ economic interests are potentially adverse
to your interests as an investor in the securities. |
In connection with our normal business activities and in
connection with hedging our obligations under the securities, we and our affiliates make markets in and trade various financial instruments
or products for our accounts and for the account of our clients and otherwise provide investment banking and other financial services
with respect to these financial instruments and products. These financial instruments and products may include securities, derivative
instruments or assets that may relate to an underlier or its components. In any such market making, trading and hedging activity, investment
banking and other financial services, we or our affiliates may take positions or take actions that are inconsistent with, or adverse to,
the investment objectives of the holders of the securities. We and our affiliates have no obligation to take the needs of any buyer, seller
or holder of the securities into account in conducting these activities. Such market making, trading and hedging activity, investment
banking and other financial services may negatively impact the value of the securities.
In addition, the role played by Barclays Capital Inc., as
the agent for the securities, could present significant conflicts of interest with the role of Barclays Bank PLC, as issuer of the securities.
For example, Barclays Capital Inc. or its representatives may derive compensation or financial benefit from the distribution of the securities
and such compensation or financial benefit may serve as an incentive to sell the securities instead of other investments. Furthermore,
we and our affiliates establish the offering price of the securities for initial sale to the public, and the offering price is not based
upon any independent verification or valuation.
Furthermore, the selected dealer or its affiliates will have
the option to conduct a material portion of the hedging activities for us in connection with the securities. The selected dealer or its
affiliates would expect to realize a projected profit from such hedging activities, and this projected profit would be in addition to
any selling concession that the selected dealer realizes for the sale of the securities to you. This additional projected profit may create
a further incentive for the selected dealer to sell the securities to you.
In addition to the activities described
above, we will also act as the calculation agent for the securities. As calculation agent, we will determine any values of the underliers
and make any other determinations necessary to calculate any payments on the securities. In making these determinations, we may be required
to make discretionary judgments, including those described in the accompanying prospectus supplement and under “—Risks Relating
to the Underliers” above. In making these discretionary judgments, our economic interests are potentially adverse to your interests
as an investor in the securities, and any of these determinations may adversely affect any payments on the securities.

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
Risks Relating to the Estimated Value of the Securities
and the Secondary Market
| § | The securities will not be listed on any securities exchange,
and secondary trading may be limited. Barclays Capital Inc. and other affiliates of Barclays Bank PLC intend to offer to purchase
the securities in the secondary market but are not required to do so and may cease any such market making activities at any time, without
notice. Even if a secondary market develops, it may not provide enough liquidity to allow you to trade or sell the securities easily.
Because other dealers are not likely to make a secondary market for the securities, the price, if any, at which you may be able to trade
your securities is likely to depend on the price, if any, at which Barclays Capital Inc. and other affiliates of Barclays Bank PLC are
willing to buy the securities. In addition, Barclays Capital Inc. or one or more of our other affiliates may at any time hold an unsold
portion of the securities (as described on the cover page of this document), which may inhibit the development of a secondary market for
the securities. The securities are not designed to be short-term trading instruments. Accordingly, you should be willing and able to hold
your securities to maturity. |
| § | The market price of the securities will be influenced
by many unpredictable factors. Several factors will influence the value of the securities in the secondary market and the price at
which Barclays Capital Inc. and other affiliates of Barclays Bank PLC may be willing to purchase or sell the securities in the secondary
market. Although we expect that generally the values of the underliers on any day will affect the value of the securities more than any
other single factor, other factors that may influence the value of the securities include: |
| o | the volatility (frequency and magnitude of changes in value) of each underlier; |
| o | whether the closing level of any underlier has been, or is expected to be, below its coupon barrier level on any determination date
and whether the final underlier value of any underlier is expected to be below its downside threshold level; |
| o | correlation (or lack of correlation) of the underliers; |
| o | dividend rates on the securities composing the underliers; |
| o | interest and yield rates in the market; |
| o | time remaining until the securities mature; |
| o | supply and demand for the securities; |
| o | geopolitical conditions and economic, financial, political, regulatory and judicial events that affect the securities composing the
underliers and that may affect the final underlier values; |
| o | the exchange rates relative to the U.S. dollar with respect to each of the currencies in which the securities composing the MXEA Index
trade; and |
| o | any actual or anticipated changes in our credit ratings or credit spreads. |
The values of the underliers may be, and have recently been,
volatile, and we can give you no assurance that the volatility will lessen. See “MSCI EAFE® Index Overview,”
“Russell 2000® Index Overview” and “S&P 500® Index Overview” below. You may
receive less, and possibly significantly less, than the stated principal amount if you try to sell your securities prior to maturity.
| § | The estimated value of your securities is expected to
be lower than the initial issue price of your securities. The estimated value of your securities on the pricing date is expected to
be lower, and may be significantly lower, than the initial issue price of your securities. The difference between the initial issue price
of your securities and the estimated value of the securities is expected as a result of certain factors, such as any sales commissions
expected to be paid to Barclays Capital Inc. or another affiliate of ours, any selling concessions, discounts, commissions or fees expected
to be allowed or paid to non-affiliated intermediaries, the estimated profit that we or any of our affiliates expect to earn in connection
with structuring the securities, the estimated cost that we may incur in hedging our obligations under the securities, and estimated development
and other costs that we may incur in connection with the securities. These other costs will include a fee paid to LFT Securities, LLC,
an entity in which an affiliate of Morgan Stanley Wealth Management has an ownership interest, for providing certain electronic platform
services with respect to this offering. |
| § | The estimated value of your securities might be lower
if such estimated value were based on the levels at which our debt securities trade in the secondary market. The estimated value of
your securities on the pricing date is based on a number of variables, including our internal funding rates. Our internal funding rates
may vary from the levels at which our benchmark debt securities trade in the secondary market. As a result of this difference, the estimated
values referenced above might be lower if such estimated values were based on the levels at which our benchmark debt securities trade
in the secondary market. |
| § | The estimated value of the securities is based on our
internal pricing models, which may prove to be inaccurate and may be different from the pricing models of other financial institutions.
The estimated value of your securities on the pricing date is based on our internal pricing models, which take into account a number
of variables and are based on a number of subjective assumptions, which may or may not materialize. These variables and assumptions are
not evaluated or verified on an independent basis. Further, our pricing models may be different from other financial institutions’
pricing models and the methodologies used by us to estimate the value of the securities may not be consistent with those of other financial
institutions that may be purchasers or |

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
sellers of securities in the secondary market. As a result,
the secondary market price of your securities may be materially different from the estimated value of the securities determined by reference
to our internal pricing models.
| § | The estimated value of your securities is not a prediction
of the prices at which you may sell your securities in the secondary market, if any, and such secondary market prices, if any, will likely
be lower than the initial issue price of your securities and may be lower than the estimated value of your securities. The estimated
value of the securities will not be a prediction of the prices at which Barclays Capital Inc., other affiliates of ours or third parties
may be willing to purchase the securities from you in secondary market transactions (if they are willing to purchase, which they are not
obligated to do). The price at which you may be able to sell your securities in the secondary market at any time will be influenced by
many factors that cannot be predicted, such as market conditions, and any bid and ask spread for similar sized trades, and may be substantially
less than our estimated value of the securities. Further, as secondary market prices of your securities take into account the levels at
which our debt securities trade in the secondary market, and do not take into account our various costs related to the securities such
as fees, commissions, discounts, and the costs of hedging our obligations under the securities, secondary market prices of your securities
will likely be lower than the initial issue price of your securities. As a result, the price at which Barclays Capital Inc., other affiliates
of ours or third parties may be willing to purchase the securities from you in secondary market transactions, if any, will likely be lower
than the price you paid for your securities, and any sale prior to the maturity date could result in a substantial loss to you. |
| § | The temporary price at which we may initially buy the
securities in the secondary market and the value we may initially use for customer account statements, if we provide any customer account
statements at all, may not be indicative of future prices of your securities. Assuming that all relevant factors remain constant after
the pricing date, the price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market (if Barclays
Capital Inc. makes a market in the securities, which it is not obligated to do) and the value that we may initially use for customer account
statements, if we provide any customer account statements at all, may exceed our estimated value of the securities on the pricing date,
as well as the secondary market value of the securities, for a temporary period after the initial issue date of the securities. The price
at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market and the value that we may initially use
for customer account statements may not be indicative of future prices of your securities. |

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
MSCI EAFE® Index Overview
The MXEA Index is a free float-adjusted market capitalization index
that is designed to measure the equity market performance of the large- and mid-cap segments of certain developed markets, excluding the
United States and Canada. For more information about the MXEA Index, see “Indices—The MSCI Indices” in the accompanying
underlying supplement.
Information about the MXEA Index as of market close on June 20, 2025:
Bloomberg Ticker Symbol: |
MXEA |
52 Week High: |
2,643.82 |
Current Closing Level: |
2,575.17 |
52 Week Low: |
2,142.94 |
52 Weeks Ago (6/21/2024): |
2,307.56 |
|
|
The following table sets forth the published high, low and period-end
closing levels of the MXEA Index for each quarter for the period of January 2, 2020 through June 20, 2025. The associated graph shows
the closing levels of the MXEA Index for each day in the same period. The closing level of the MXEA Index on June 20, 2025 was 2,575.17.
We obtained the closing levels of the MXEA Index from Bloomberg Professional® service (“Bloomberg”), without
independent verification. Historical performance of the MXEA Index should not be taken as an indication of future performance. Future
performance of the MXEA Index may differ significantly from historical performance, and no assurance can be given as to the closing level
of the MXEA Index during the term of the securities, including on any of the determination dates. We cannot give you assurance that the
performance of the MXEA Index will not result in a loss on your initial investment.
MSCI EAFE® Index |
High |
Low |
Period End |
2020 |
|
|
|
First Quarter |
2,057.74 |
1,354.30 |
1,559.59 |
Second Quarter |
1,854.00 |
1,487.08 |
1,780.58 |
Third Quarter |
1,925.15 |
1,783.59 |
1,855.32 |
Fourth Quarter |
2,161.48 |
1,780.08 |
2,147.53 |
2021 |
|
|
|
First Quarter |
2,256.88 |
2,124.05 |
2,208.32 |
Second Quarter |
2,382.76 |
2,219.15 |
2,304.92 |
Third Quarter |
2,404.80 |
2,253.68 |
2,281.29 |
Fourth Quarter |
2,377.93 |
2,223.70 |
2,336.07 |
2022 |
|
|
|
First Quarter |
2,365.59 |
1,977.61 |
2,181.63 |
Second Quarter |
2,182.74 |
1,823.08 |
1,846.28 |
Third Quarter |
1,970.07 |
1,654.25 |
1,661.48 |
Fourth Quarter |
2,013.56 |
1,647.94 |
1,943.93 |
2023 |
|
|
|
First Quarter |
2,133.83 |
1,955.87 |
2,092.60 |
Second Quarter |
2,170.84 |
2,041.81 |
2,131.72 |
Third Quarter |
2,199.36 |
2,019.39 |
2,031.26 |
Fourth Quarter |
2,241.21 |
1,942.89 |
2,236.16 |
2024 |
|
|
|
First Quarter |
2,357.74 |
2,162.91 |
2,349.42 |
Second Quarter |
2,386.13 |
2,236.31 |
2,314.63 |
Third Quarter |
2,506.69 |
2,206.30 |
2,468.66 |
Fourth Quarter |
2,454.84 |
2,235.78 |
2,261.81 |
2025 |
|
|
|
First Quarter |
2,511.97 |
2,227.28 |
2,400.82 |
Second Quarter (through June 20, 2025) |
2,643.82 |
2,142.94 |
2,575.17 |

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
MXEA Index Historical Performance*
January 2, 2020 to June 20, 2025 |
 |
* The dotted lines indicate a hypothetical coupon barrier level and a hypothetical downside threshold level of 70% and 60%, respectively, of the closing level of the MXEA Index on June 20, 2025. The actual coupon barrier level and downside threshold level will be equal to 70% and 60%, respectively, of the initial underlier value of the MXEA Index. |
Past
performance is not indicative of future results.

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
Russell 2000® Index Overview
The RTY Index measures the capitalization-weighted price performance
of 2,000 U.S. small-capitalization stocks listed on eligible U.S. exchanges and is designed to track the performance of the small-capitalization
segment of the U.S. equity market. For more information about the RTY Index, see “Indices—The Russell Indices” in the
accompanying underlying supplement.
Information about the RTY Index as of market close on June 20, 2025:
Bloomberg Ticker Symbol: |
RTY |
52 Week High: |
2,442.031 |
Current Closing Level: |
2,109.267 |
52 Week Low: |
1,760.710 |
52 Weeks Ago (6/21/2024): |
2,022.034 |
|
|
The following table sets forth the published high, low and period-end
closing levels of the RTY Index for each quarter for the period of January 2, 2020 through June 20, 2025. The associated graph shows the
closing levels of the RTY Index for each day in the same period. The closing level of the RTY Index on June 20, 2025 was 2,109.267. We
obtained the closing levels of the RTY Index from Bloomberg, without independent verification. Historical performance of the RTY Index
should not be taken as an indication of future performance. Future performance of the RTY Index may differ significantly from historical
performance, and no assurance can be given as to the closing level of the RTY Index during the term of the securities, including on any
of the determination dates. We cannot give you assurance that the performance of the RTY Index will not result in a loss on your initial
investment.
Russell 2000® Index |
High |
Low |
Period End |
2020 |
|
|
|
First Quarter |
1,705.215 |
991.160 |
1,153.103 |
Second Quarter |
1,536.895 |
1,052.053 |
1,441.365 |
Third Quarter |
1,592.287 |
1,398.920 |
1,507.692 |
Fourth Quarter |
2,007.104 |
1,531.202 |
1,974.855 |
2021 |
|
|
|
First Quarter |
2,360.168 |
1,945.914 |
2,220.519 |
Second Quarter |
2,343.758 |
2,135.139 |
2,310.549 |
Third Quarter |
2,329.359 |
2,130.680 |
2,204.372 |
Fourth Quarter |
2,442.742 |
2,139.875 |
2,245.313 |
2022 |
|
|
|
First Quarter |
2,272.557 |
1,931.288 |
2,070.125 |
Second Quarter |
2,095.440 |
1,649.836 |
1,707.990 |
Third Quarter |
2,021.346 |
1,655.882 |
1,664.716 |
Fourth Quarter |
1,892.839 |
1,682.403 |
1,761.246 |
2023 |
|
|
|
First Quarter |
2,001.221 |
1,720.291 |
1,802.484 |
Second Quarter |
1,896.333 |
1,718.811 |
1,888.734 |
Third Quarter |
2,003.177 |
1,761.609 |
1,785.102 |
Fourth Quarter |
2,066.214 |
1,636.938 |
2,027.074 |
2024 |
|
|
|
First Quarter |
2,124.547 |
1,913.166 |
2,124.547 |
Second Quarter |
2,109.459 |
1,942.958 |
2,047.691 |
Third Quarter |
2,263.674 |
2,026.727 |
2,229.970 |
Fourth Quarter |
2,442.031 |
2,180.146 |
2,230.158 |
2025 |
|
|
|
First Quarter |
2,317.968 |
1,993.690 |
2,011.913 |
Second Quarter (through June 20, 2025) |
2,156.407 |
1,760.710 |
2,109.267 |

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
RTY Index Historical Performance*
January 2, 2020 to June 20, 2025 |
 |
* The dotted lines indicate a
hypothetical coupon barrier level and a hypothetical downside threshold level of 70% and 60%, respectively, of the closing level
of the RTY Index on June 20, 2025. The actual coupon barrier level and downside threshold level will be equal to 70% and 60%, respectively,
of the initial underlier value of the RTY Index. |
Past
performance is not indicative of future results.

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
S&P 500® Index Overview
The SPX Index consists of stocks of 500 companies selected to provide
a performance benchmark for the U.S. equity markets. For more information about the SPX Index, see “Indices—The S&P U.S.
Indices” in the accompanying underlying supplement.
Information about the SPX Index as of market close on June 20, 2025:
Bloomberg Ticker Symbol: |
SPX |
52 Week High: |
6,144.15 |
Current Closing Level: |
5,967.84 |
52 Week Low: |
4,982.77 |
52 Weeks Ago (6/21/2024): |
5,464.62 |
|
|
The following table sets forth the published high, low and period-end
closing levels of the SPX Index for each quarter for the period of January 2, 2020 through June 20, 2025. The associated graph shows the
closing levels of the SPX Index for each day in the same period. The closing level of the SPX Index on June 20, 2025 was 5,967.84. We
obtained the closing levels of the SPX Index from Bloomberg, without independent verification. Historical performance of the SPX Index
should not be taken as an indication of future performance. Future performance of the SPX Index may differ significantly from historical
performance, and no assurance can be given as to the closing level of the SPX Index during the term of the securities, including on any
of the determination dates. We cannot give you assurance that the performance of the SPX Index will not result in a loss on your initial
investment.
S&P 500® Index |
High |
Low |
Period End |
2020 |
|
|
|
First Quarter |
3,386.15 |
2,237.40 |
2,584.59 |
Second Quarter |
3,232.39 |
2,470.50 |
3,100.29 |
Third Quarter |
3,580.84 |
3,115.86 |
3,363.00 |
Fourth Quarter |
3,756.07 |
3,269.96 |
3,756.07 |
2021 |
|
|
|
First Quarter |
3,974.54 |
3,700.65 |
3,972.89 |
Second Quarter |
4,297.50 |
4,019.87 |
4,297.50 |
Third Quarter |
4,536.95 |
4,258.49 |
4,307.54 |
Fourth Quarter |
4,793.06 |
4,300.46 |
4,766.18 |
2022 |
|
|
|
First Quarter |
4,796.56 |
4,170.70 |
4,530.41 |
Second Quarter |
4,582.64 |
3,666.77 |
3,785.38 |
Third Quarter |
4,305.20 |
3,585.62 |
3,585.62 |
Fourth Quarter |
4,080.11 |
3,577.03 |
3,839.50 |
2023 |
|
|
|
First Quarter |
4,179.76 |
3,808.10 |
4,109.31 |
Second Quarter |
4,450.38 |
4,055.99 |
4,450.38 |
Third Quarter |
4,588.96 |
4,273.53 |
4,288.05 |
Fourth Quarter |
4,783.35 |
4,117.37 |
4,769.83 |
2024 |
|
|
|
First Quarter |
5,254.35 |
4,688.68 |
5,254.35 |
Second Quarter |
5,487.03 |
4,967.23 |
5,460.48 |
Third Quarter |
5,762.48 |
5,186.33 |
5,762.48 |
Fourth Quarter |
6,090.27 |
5,695.94 |
5,881.63 |
2025 |
|
|
|
First Quarter |
6,144.15 |
5,521.52 |
5,611.85 |
Second Quarter (through June 20, 2025) |
6,045.26 |
4,982.77 |
5,967.84 |

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
SPX Index Historical Performance*
January 2, 2020 to June 20, 2025 |
 |
* The dotted lines indicate a
hypothetical coupon barrier level and a hypothetical downside threshold level of 70% and 60%, respectively, of the closing level
of the SPX Index on June 20, 2025. The actual coupon barrier level and downside threshold level will be equal to 70% and 60%, respectively,
of the initial underlier value of the SPX Index. |
Past
performance is not indicative of future results.

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
Additional Information about the Securities
Please read this information in conjunction with the terms on the cover
page of this document.
Additional provisions: |
|
Minimum ticketing size: |
$1,000 / 1 security |
Tax considerations: |
You should review carefully the sections in the accompanying prospectus
supplement entitled “Material U.S. Federal Income Tax Consequences—Tax Consequences to U.S. Holders—Notes Treated as
Prepaid Forward or Derivative Contracts with Associated Contingent Coupons” and, if you are a non-U.S. holder, “—Tax
Consequences to Non-U.S. Holders.”
In determining our reporting responsibilities, if any, we intend to
treat (i) the securities for U.S. federal income tax purposes as prepaid forward contracts with associated contingent coupons and (ii)
any contingent quarterly payments as ordinary income, as described in the section entitled “Material U.S. Federal Income Tax Consequences—Tax
Consequences to U.S. Holders—Notes Treated as Prepaid Forward or Derivative Contracts with Associated Contingent Coupons”
in the accompanying prospectus supplement. Our special tax counsel, Davis Polk & Wardwell LLP, has advised that it believes this treatment
to be reasonable, but that there are other reasonable treatments that the Internal Revenue Service (the “IRS”) or a court
may adopt.
Sale, exchange or redemption of a security. Assuming the treatment
described above is respected, upon a sale or exchange of the securities (including upon early redemption or redemption at maturity), you
should recognize capital gain or loss equal to the difference between the amount realized on the sale or exchange and your tax basis in
the securities, which should equal the amount you paid to acquire the securities (assuming contingent quarterly payments are properly
treated as ordinary income, consistent with the position referred to above). This gain or loss should be short-term capital gain or loss
unless you hold the securities for more than one year, in which case the gain or loss should be long-term capital gain or loss, whether
or not you are an initial purchaser of the securities at the issue price. The deductibility of capital losses is subject to limitations.
If you sell your securities between the time your right to a contingent quarterly payment is fixed and the time it is paid, it is likely
that you will be treated as receiving ordinary income equal to the contingent quarterly payment. Although uncertain, it is possible that
proceeds received from the sale or exchange of your securities prior to a determination date but that can be attributed to an expected
contingent quarterly payment could be treated as ordinary income. You should consult your tax advisor regarding this issue.
As noted above, there are other reasonable treatments that the IRS or
a court may adopt, in which case the timing and character of any income or loss on the securities could be materially affected. In addition,
in 2007 the U.S. Treasury Department and the IRS released a notice requesting comments on the U.S. federal income tax treatment of “prepaid
forward contracts” and similar instruments. The notice focuses in particular on whether to require investors in these instruments
to accrue income over the term of their investment. It also asks for comments on a number of related topics, including the character of
income or loss with respect to these instruments and the relevance of factors such as the nature of the underlying property to which the
instruments are linked. While the notice requests comments on appropriate transition rules and effective dates, any Treasury regulations
or other guidance promulgated after consideration of these issues could materially affect the tax consequences of an investment in the
securities, possibly with retroactive effect. You should consult your tax advisor regarding the U.S. federal income tax consequences of
an investment in the securities, including possible alternative treatments and the issues presented by this notice.
Non-U.S. holders. Insofar as we have responsibility as a withholding
agent, we do not currently intend to treat contingent quarterly payments to non-U.S. holders (as defined in the accompanying prospectus
supplement) as subject to U.S. withholding tax. However, non-U.S. holders should in any event expect to be required to provide appropriate
Forms W-8 or other documentation in order to establish an exemption from backup withholding, as described under the heading “—Information
Reporting and Backup Withholding” in the accompanying prospectus supplement. If any withholding is required, we will not be required
to pay any additional amounts with respect to amounts withheld.
Treasury regulations under Section 871(m) generally impose a withholding
tax on certain “dividend equivalents” under certain “equity linked instruments.” A recent IRS notice excludes
from the scope of Section 871(m) instruments issued prior to January 1, 2027 that do not have a “delta of one” with respect
to underlying securities that could pay U.S.-source dividends for U.S. federal income tax purposes (each an “Underlying Security”).
Based on our determination that the securities do not have a “delta of one” within the meaning of the regulations, we expect
that these regulations will not |

Contingent Income Callable Securities due July 2, 2030
Based on the Value of the Worst Performing of the MSCI EAFE® Index, the Russell 2000® Index and the S&P 500® Index
Principal at Risk Securities
|
apply to the securities with regard to non-U.S. holders. Our determination is not binding on the IRS, and the IRS may disagree with this determination. Section 871(m) is complex and its application may depend on your particular circumstances, including whether you enter into other transactions with respect to an Underlying Security. If necessary, further information regarding the potential application of Section 871(m) will be provided in the pricing supplement for the securities. You should consult your tax advisor regarding the potential application of Section 871(m) to the securities. |
Trustee: |
The Bank of New York Mellon |
Use of proceeds and hedging: |
The net proceeds we receive from the sale of the
securities will be used for various corporate purposes as set forth in the prospectus and prospectus supplement and, in part, in
connection with hedging our obligations under the securities through one or more of our subsidiaries.
We, through our subsidiaries or others, hedge
our anticipated exposure in connection with the securities by taking positions in futures and options contracts on the underliers and
any other securities or instruments we may wish to use in connection with such hedging. Trading and other transactions by us or
our affiliates could affect the values of the underliers, the market value of the securities or any amounts payable on the securities. For
further information on our use of proceeds and hedging, see “Use of Proceeds and Hedging” in the prospectus supplement. |
ERISA: |
See “Benefit Plan Investor Considerations” in the accompanying prospectus supplement. |
This document represents a summary of the terms and conditions of
the securities. We encourage you to read the accompanying prospectus, prospectus supplement and underlying supplement for this offering,
which can be accessed via the hyperlinks on the cover page of this document.
Supplemental Plan of Distribution
Morgan Stanley Smith Barney LLC (“Morgan Stanley Wealth Management”)
and its financial advisors will collectively receive from the agent, Barclays Capital Inc., a fixed sales commission for each security
they sell, and Morgan Stanley Wealth Management will receive a structuring fee for each security, in each case as specified on the cover
page of this document.